Clinical Trial Update: Triheptanoin (UX007) to Treat Citrate Transporter Deficiency

View source ↗

Summary

Clinical trial update on Triheptanoin (UX007) for citrate transporter deficiency caused by SLC13A5 mutation; the trial is no longer available for enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Citrate Transporter Deficiency

Drugs mentioned

• Triheptanoin (triheptanoin)

Snippet

Sponsor: Irina A Anselm | Conditions: Citrate Transporter Deficiency, SLC13A5 Gene Mutation | Status: NO_LONGER_AVAILABLE